John Vernachio
Impact in
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
-
- Antimicrobial Resistance in Staphylococcus 9
- HIV/AIDS drug development and treatment 3
-
- Biochemical and Structural Characterization 4
- Co-authors
- Joseph M. Patti (12 shared papers)Peter J. Syribeys (8 shared papers)Elena Gorovits (7 shared papers)Jeff Hutchins (8 shared papers)Mark J. Soloski (2 shared papers)Andrea Hall (6 shared papers)Brenda Ames (5 shared papers)Paul Domanski (4 shared papers)
- Journals
- Infection and Immunity (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)BioTechniques (1 paper)Clinical and Vaccine Immunology (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
John Vernachio
22 papers receiving 911 citations
Peers
Comparison fields: 5 of 81
- Infectious Diseases 549
- Microbiology 89
- Immunology 203
- Molecular Biology 469
- Epidemiology 191
Countries citing papers authored by John Vernachio
This map shows the geographic impact of John Vernachio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Vernachio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Vernachio more than expected).
Fields of papers citing papers by John Vernachio
This network shows the impact of papers produced by John Vernachio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Vernachio. The network helps show where John Vernachio may publish in the future.
Co-authors
The 25 scholars most cited alongside John Vernachio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 113 | |
| 2 | 2004 | 104 | |
| 3 | 2003 | 81 | |
| 4 | 2010 | 73 | |
| 5 | 2005 | 59 | |
| 6 | 2009 | 57 | |
| 7 | 2012 | 56 | |
| 8 | 2015 | 56 | |
| 9 | 2006 | 55 | |
| 10 | 1986 | 54 | |
| 11 | 1989 | 49 | |
| 12 | 1998 | 28 | |
| 13 | 2018 | 26 | |
| 14 | 2013 | 26 | |
| 15 | 2007 | 22 | |
| 16 | 2004 | 19 | |
| 17 | 2022 | 18 | |
| 18 | Metastasizing neuroblastomas in mice transgenic for simian virus 40 large T (SV40T) under the olfactory marker protein gene promoter. | 1994 | 17 |
| 19 | 1993 | 16 | |
| 20 | 1999 | 16 |
About John Vernachio
John Vernachio is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Public Health, Environmental and Occupational Health and Immunology, having authored 23 papers that have together received 965 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (9 papers), Streptococcal Infections and Treatments (4 papers), Biochemical and Structural Characterization (4 papers), Hepatitis C virus research (4 papers), HIV/AIDS drug development and treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Infective Endocarditis Diagnosis and Management (3 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Infectious Diseases (549 citations), Microbiology (89 citations), Immunology (203 citations), Molecular Biology (469 citations) and Epidemiology (191 citations). John Vernachio has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Joseph M. Patti, Peter J. Syribeys, Elena Gorovits, Jeff Hutchins, Mark J. Soloski, Andrea Hall, Brenda Ames, Paul Domanski, Arnold S. Bayer and Bradley D. Prater. Their work appears in journals such as Infection and Immunity, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, BioTechniques and Clinical and Vaccine Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.